Invention Grant
- Patent Title: Compounds
-
Application No.: US15712366Application Date: 2017-09-22
-
Publication No.: US10023558B2Publication Date: 2018-07-17
- Inventor: Jonathan Mark Sutton , Robert Andrew Heald , Andrew Stephen Robert Jennings , Carmelida Capaldi , Elisabetta Armani
- Applicant: CHIESI FARMACEUTICI S.P.A.
- Applicant Address: IT Parma
- Assignee: CHIESI FARMACEUTICI S.P.A.
- Current Assignee: CHIESI FARMACEUTICI S.P.A.
- Current Assignee Address: IT Parma
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: EP16172196 20160531
- Main IPC: C07D403/04
- IPC: C07D403/04 ; C07D401/14 ; C07D413/14 ; C07D417/14 ; C07D471/04 ; A61K31/454 ; A61K31/4155 ; A61K31/4178 ; A61K31/4196 ; C07C309/29 ; C07D403/14
Abstract:
Compounds of formula (I) defined herein exhibit human neutrophil elastase inhibitory properties and are useful for the treatment of disease or conditions in which HNE is implicated.
Public/Granted literature
- US20180009787A1 NOVEL COMPOUNDS Public/Granted day:2018-01-11
Information query
